OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $69 | -100.0% | 13,383 | +5.9% | 0.01% | -70.6% |
| Q2 2021 | $179,000 | -31.7% | 12,641 | -20.7% | 0.02% | -10.5% |
| Q1 2021 | $262,000 | +77.0% | 15,938 | -18.1% | 0.02% | -24.0% |
| Q3 2020 | $148,000 | -21.7% | 19,459 | -59.3% | 0.02% | +38.9% |
| Q4 2019 | $189,000 | +509.7% | 47,820 | +374.2% | 0.02% | +800.0% |
| Q3 2019 | $31,000 | -77.9% | 10,085 | -51.2% | 0.00% | -66.7% |
| Q2 2018 | $140,000 | +6.9% | 20,672 | +2.6% | 0.01% | -14.3% |
| Q1 2018 | $131,000 | -53.2% | 20,139 | -68.0% | 0.01% | -53.3% |
| Q4 2017 | $280,000 | – | 63,020 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |